Figure 1
From: Differential activity of innate defense antimicrobial peptides against Nocardia species
Activity of human AMPs HNP 1-3, hBD-3, LL-37 and levofloxacin (killing control) against A N. farcinca ATCC 3318 (p < 0.05 for all tested substances), B N. nova ATCC 33726 (p < 0.05 for all tested substances), C N. asteroides ATCC 19247 (levofloxacin p < 0.05, HNP1-3 p = 0.11) and D N. brasiliensis ATCC 19296 (levofloxacin p < 0.05) was investigated using a colony forming unit (CFU) assay. Data are means (percent CFU reduction) of at least four independent sets of experiments with each peptide and each Nocardia species.